Cargando…
Potential metabolite markers of schizophrenia
Schizophrenia is a severe mental disorder that affects 0.5–1% of the population worldwide. Current diagnostic methods are based on psychiatric interviews, which are subjective in nature. The lack of disease biomarkers to support objective laboratory tests has been a long-standing bottleneck in the c...
Autores principales: | Yang, J, Chen, T, Sun, L, Zhao, Z, Qi, X, Zhou, K, Cao, Y, Wang, X, Qiu, Y, Su, M, Zhao, A, Wang, P, Yang, P, Wu, J, Feng, G, He, L, Jia, W, Wan, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526727/ https://www.ncbi.nlm.nih.gov/pubmed/22024767 http://dx.doi.org/10.1038/mp.2011.131 |
Ejemplares similares
-
Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study
por: Yang, X, et al.
Publicado: (2017) -
Local-to-remote cortical connectivity in early- and adulthood-onset schizophrenia
por: Jiang, L, et al.
Publicado: (2015) -
Characterization of Tamyb10 allelic variants and development of STS marker for pre-harvest sprouting resistance in Chinese bread wheat
por: Wang, Y., et al.
Publicado: (2016) -
DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016) -
Potential physics measurement with ALICE electromagnetic calorimeters
por: Zhou, D C, et al.
Publicado: (2010)